Navigation Links
Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals
Date:9/19/2007

BOSTON, Sept. 19 /PRNewswire-USNewswire/ -- The United States District Court for the District of Massachusetts has granted preliminary approval of two Proposed Settlements on behalf of a class of people and entities that purchased certain prescription drugs. Plaintiffs filed the lawsuits, New England Carpenters Health Benefits Fund v. First DataBank, Inc., No. 1:05-CV-11148-PBS and D.C. 37 Health & Security Plan v. Medi-Span, No. 07-cv-10988-PBS, concerning how the published price of drugs are determined, what consumers pay for the drugs and what third party payors reimburse for them.

First DataBank, Inc., ("FDB") and Medi-Span publish data related to the prices of prescription drugs in their printed and electronic databases. The data includes the Average Wholesale Price ("AWP") of each drug. Pharmaceutical manufacturers report certain prices to FDB and Medi-Span. FDB then marked-up these prices to get the AWP reported in their publications and databases. From December 2001 into April 2004, Medi-Span published Average Wholesale Prices that it obtained from FDB. Subsequently, Medi-Span independently published certain AWP information in its publications and databases. Third-party payors and pharmacies may use the AWP as a benchmark in determining the amount of reimbursement for drugs or the cost of drugs to certain consumers.

One of the lawsuits alleges that FDB and McKesson Corporation wrongfully inflated the mark-up used to determine the AWP. The other lawsuit claims that Medi-Span negligently published inflated prescription drug prices. As a result, the two lawsuits claim that insurers, Third-Party Payors ("TPPs") and some consumers paid more for certain drugs than they should have.

"Although the Proposed Settlements do not provide money to consumers right now, they will likely allow certain consumers to save millions of dollars in future prescription drug costs," said Jeffrey Kodroff of Spector Roseman & Kodroff P.C. and Thomas M. Sobol of Hagens Berman Sobol Shapiro LLP, Counsel for the Plaintiffs in this case. "This is a first step in making all prescription drugs more affordable for consumers."

The Proposed Settlements provide "injunctive relief." This means that instead of paying money damages, the companies agree to change what they are doing to benefit the Class. In these lawsuits, a substantial benefit is provided to the Class because FDB and Medi-Span will:

-- Reduce the mark-up factor for thousands of drugs in their respective

data publications. Class Counsel estimate that this reduction may

save well over a billion dollars in future drug costs for consumers,

insurers and TPPs in a single 12-month period.

-- Cease to publish an AWP within two (FDB) or three (Medi-Span) years

of the Proposed Settlements final approval.

-- Provide information on drug price publishing in connection with this

and other lawsuits. Class counsel believe this will likely provide

additional benefits, including monetary benefits, to Class Members

in drug pricing lawsuits against other parties.

"First DataBank denies that it has any liability as a publisher of information that relies on data provided by others. First DataBank is dedicated to reporting relevant and reliable drug information, which we believe this settlement promotes," said Eve Burton, legal counsel for FDB. "Medi-Span denies wrongdoing and will continue to serve as a reputable publisher of drug price information provided to Medi-Span by third parties," said Eric Cardinal, Director Drug File Products for Medi-Span.

The Class consists of all individual persons or entities that made purchases and/or paid, whether directly, indirectly, or by reimbursement, for all or part of the purchase price of certain prescription pharmaceuticals based on the AWP data reported by FDB or Medi-Span. Consumers who pay a fixed co-pay for prescription drugs are not affected by this settlement.

The Court will hold a Final Approval Hearing on January 22, 2008 at 2:00 p.m. to consider whether the Proposed Settlements are fair, reasonable, and adequate and the motion for attorneys' fees and expenses. For more information regarding the Class Action visit http://www.FDBMediSpanSettlement.com.


'/>"/>
SOURCE FDB/Medi-Span Settlement Administrator
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. “ Economy Class Syndrome
2. Latest Tumor Classification More Informative
3. Ultrasound may mean end to classic stethoscope
4. Self-Applied Acupressure May Reduce Sleepiness And Increase Alertness During Class Hours
5. Madhya Pradesh Cops to attend Yoga classes to reduce stress and weight
6. Sunflowers Could Hold the Key to New Class of AIDS Drugs
7. Campaigners Say No To Cannabis Reclassification
8. Kolkata To Get World-Class Cancer Hospital Soon
9. Peer Rejection Leads To Reduced Participation In Classroom Activities
10. East London Receives World Class New Private Hospital Facility
11. Welcome to ‘Stand Only’ Classrooms That Exercise The Brain And The Bod!
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... Premier Fitness Camp (PFC) and ... the ultimate weight loss and wellness program, at their world headquarters of Omni La ... immediate and long-term results to anyone seeking weight loss, personal development, a healthy lifestyle, ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... continuity to its innovative Unified Instance Manager architecture, meeting the needs of ... new version optimizes the unattended auto-dialing system without agents, Presence Robodialer, provides ...
(Date:12/8/2016)... ... 08, 2016 , ... STATEN ISLAND, N.Y., Nov. 24, 2016 ... the highest standards of trauma, maternity, cancer and chronic obstructive pulmonary disease (COPD) ... Dr. Daniel Messina. , Among the recognitions, the American College of Surgeons' (ACS) ...
(Date:12/8/2016)... ... December 08, 2016 , ... California Senate Bill (SB) 863, signed into law ... in 2013 and 2014, according to CompScope™ Medical Benchmarks for California, 17th Edition ... to the study, medical payments per claim in California decreased 4 percent in 2013 ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... Care Act. Dr. Botelho advocates for the mass media launching of story movements ... ongoing opportunities to share their unfortunate experiences; such a movement can generate the ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016 Henry Schein, Inc. (Nasdaq: ... care products and services to office-based dental, animal health and ... equity investment in Marrodent, one of Poland,s ... $32 million. This transaction was announced on August 30, 2016. ... Poland since 2014, and Marrodent marks ...
(Date:12/8/2016)... 2016 Research and Markets has announced the addition ... to their offering. ... The report provides separate comprehensive analytics for ... and Rest of World. Annual estimates and forecasts are ... is provided for these markets. Market data and analytics are derived from ...
(Date:12/7/2016)... -- "Lantus (Insulin Glargine) Biosimilar Clinical Trial & Opportunity Insight" report by ... drug in clinical pipeline. Currently 5 biosimilar version of Lantus are commercially ... Kenya , Czech Republic , ... , Slovakia , United Kingdom ... patent on Lantus expired in 2014. Lantus is the brand name ...
Breaking Medicine Technology: